Back to Journals » Drug Design, Development and Therapy » Volume 5

Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial

Total article views   HTML views PDF downloads Totals
19,916 Dovepress* 16,382+ 2,446 18,828
PubMed Central* 3,534 777 4,311
Totals 19,916 3,223 23,139
*Since 11 July 2011
+Since July 2016

View citations on PubMed Central and Google Scholar